Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Qingshu Zeng"'
Autor:
Yilin Chen, Na Xu, Yunfan Yang, Zhenfang Liu, Mengxing Xue, Li Meng, Qun He, Chunyan Chen, Qingshu Zeng, Huanling Zhu, Xin Du, Jing Zou, Wenjun He, Jingming Guo, Suning Chen, Guolin Yuan, Hui Wu, Mei Hong, Fanjun Cheng, Bingcheng Liu, Yanli Zhang, Weiming Li
Publikováno v:
Cancer Medicine, Vol 12, Iss 16, Pp 17239-17252 (2023)
Abstract Background Treatment‐free remission (TFR) has become the main target for chronic myeloid leukemia (CML). Tyrosine kinase inhibitors (TKI) dose optimization is crucial in managing adverse events, and improving adherence in clinical practice
Externí odkaz:
https://doaj.org/article/9db00ffe981742fbbe1f2808187f0a3e
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Venetoclax combined with hypomethylating agents such as azacitidine and decitabine is the standard regime for the elderly patient with acute myeloid leukemia (AML) unfit for intensive induction therapy. However, many patients struggle with finances a
Externí odkaz:
https://doaj.org/article/b9a2e5c004bb42d9927bad2235669de2
Autor:
Jian Hong, Leiming Xia, Zhenqi Huang, Xiaodong Yuan, Xinglin Liang, Jifei Dai, Zhonghui Wu, Li Liang, Min Ruan, Zhangbiao Long, Xin Cheng, Xiaowen Chen, Jing Ni, Jian Ge, Qingsheng Li, Qingshu Zeng, Ruixiang Xia, Yi Wang, Mingzhen Yang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundT-cell immunoglobulin and mucin domain-containing molecule 3 (TIM-3) expresses on leukemic stem and progenitor populations of non-M3 acute myeloid leukemia (AML) as well as T lymphocytes. TIM-3 is thought to be involved in the self-renewal
Externí odkaz:
https://doaj.org/article/9f37397c5acb42c59ecb8b901be9254b
Publikováno v:
IEEE Access, Vol 8, Pp 201675-201685 (2020)
The sensor-cloud system (SCS) integrates sensors, sensor networks, and the cloud for managing sensors, collecting data, and decision-making. Smart transportation based on the sensor-cloud approach is constantly improving. The sensor cloud has promote
Externí odkaz:
https://doaj.org/article/0ee43558779e4a368a622c18df510eed
Autor:
Weiping Liu, Donglu Zhao, Ting Liu, Ting Niu, Yongping Song, Wei Xu, Jie Jin, Qingqing Cai, Huiqiang Huang, Zhiming Li, Ming Hou, Huilai Zhang, Jianfeng Zhou, Jianda Hu, Jianzhen Shen, Yuankai Shi, Yu Yang, Liling Zhang, Weili Zhao, Kaiyang Ding, Lugui Qiu, Huo Tan, Zhihui Zhang, Lihong Liu, Jinghua Wang, Bing Xu, Hui Zhou, Guangxun Gao, Hongwei Xue, Ou Bai, Ru Feng, Xiaobing Huang, Haiyan Yang, Xiaojing Yan, Qingshu Zeng, Peng Liu, Wenyu Li, Min Mao, Hang Su, Xin Wang, Jingyan Xu, Daobin Zhou, Hongyu Zhang, Jun Ma, Zhixiang Shen, Jun Zhu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Chidamide has demonstrated significant clinical benefits for patients with relapsed/refractory (R/R) PTCL in previous studies. This multi-center observational study was aimed to evaluate the objective response rate (ORR), overall survival (OS), and s
Externí odkaz:
https://doaj.org/article/5c9000aa953646639a5acb21ddd9d292
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 8 (2020)
The present study was directed toward laying new findings for Extranodal natural killer/T-cell lymphoma (ENKL)-oriented therapy with a focus on long non-coding RNA (lncRNA)–microRNAs (miRNAs)–mRNA interaction. The expression and function of XIST
Externí odkaz:
https://doaj.org/article/62161ee1593a405088d24d31b816b4d8
Autor:
Yuankai Shi, Bo Jia, Wei Xu, Wenyu Li, Ting Liu, Peng Liu, Weili Zhao, Huilai Zhang, Xiuhua Sun, Haiyan Yang, Xi Zhang, Jie Jin, Zhengming Jin, Zhiming Li, Lugui Qiu, Mei Dong, Xiaobing Huang, Yi Luo, Xiaodong Wang, Xin Wang, Jianqiu Wu, Jingyan Xu, Pingyong Yi, Jianfeng Zhou, Hongming He, Lin Liu, Jianzhen Shen, Xiaoqiong Tang, Jinghua Wang, Jianmin Yang, Qingshu Zeng, Zhihui Zhang, Zhen Cai, Xiequn Chen, Kaiyang Ding, Ming Hou, Huiqiang Huang, Xiaoling Li, Rong Liang, Qifa Liu, Yuqin Song, Hang Su, Yuhuan Gao, Lihong Liu, Jianmin Luo, Liping Su, Zimin Sun, Huo Tan, Huaqing Wang, Jingwen Wang, Shuye Wang, Hongyu Zhang, Xiaohong Zhang, Daobin Zhou, Ou Bai, Gang Wu, Liling Zhang, Yizhuo Zhang
Publikováno v:
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-5 (2017)
Abstract The efficacy and safety of chidamide, a new subtype-selective histone deacetylase (HDAC) inhibitor, have been demonstrated in a pivotal phase II clinical trial, and chidamide has been approved by the China Food and Drug Administration (CFDA)
Externí odkaz:
https://doaj.org/article/fb0461c9c99841929ebde75677646c99
Autor:
Lili Tao, Qingshu Zeng, June Li, Miao Xu, Jiajia Wang, Ying Pan, Huiping Wang, Qianshan Tao, Yang Chen, Jun Peng, Ming Hou, Arend Jan Gerard Jansen, Heyu Ni, Zhimin Zhai
Publikováno v:
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-4 (2017)
Abstract Immune thrombocytopenia (ITP) is a common autoimmune bleeding disorder. Despite considerable investigation, the pathogenesis of ITP remains incompletely understood, and for many patients, effective therapy is still unavailable. Using murine
Externí odkaz:
https://doaj.org/article/4f5466fcf96b4d5ab9b8415316110e83
Publikováno v:
IET Cyber-Physical Systems (2019)
In this work, the authors have developed an integrated evaluation hierarchy for automotive human–machine interaction (HMI) software/hardware interfaces and a corresponding set of integrated evaluation carriers and decision modes, to improve the int
Externí odkaz:
https://doaj.org/article/63bcbc4baea74b7cba2b8df05840d44e
Publikováno v:
International Journal of Laboratory Hematology. 42:849-857
INTRODUCTION Decitabine-based chemotherapy regimens have shown efficacy in the treatment of elderly patients with acute myeloid leukemia (AML). However, it remains unclear whether any molecular alteration is correlated with the therapeutic effect of